Next Level Private’s AbbVie ABBV Stock Holding History

Next Level Private’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	4,398 +168	+4%	+$36.1K	0.22%	71
2026 Q1	$920K	Buy	4,230 +875	+26%	+$194K	0.21%	76
2025 Q4	$767K	Buy	3,355 +81	+2%	+$18.5K	0.2%	85
2025 Q3	$754K	Buy	3,274 +50	+2%	+$10.2K	0.22%	77
2025 Q2	$598K	Buy	3,224 +261	+9%	+$48.5K	0.19%	79
2025 Q1	$621K	Buy	2,963 +235	+9%	+$45.7K	0.23%	75
2024 Q4	$485K	Buy	2,728 +20	+0.7%	+$3.68K	0.2%	79
2024 Q3	$535K	Buy	2,708 +350	+15%	+$65.3K	0.22%	77
2024 Q2	$404K	Sell	2,358 -561	-19%	-$92.9K	0.19%	85
2024 Q1	$531K	Buy	2,919 +1,246	+74%	+$215K	0.24%	73
2023 Q4	$259K	Sell	1,673 -54	-3%	-$7.87K	0.15%	91
2023 Q3	$256K	Buy	1,727 +88	+5%	+$12.9K	0.17%	86
2023 Q2	$220K	Buy	+1,639	New	+$240K	0.14%	94
2022 Q3	–	Sell	-23,714	Closed	-$3.63M	–	83
2022 Q2	$3.63M	Buy	+23,714	New	+$3.62M	1.39%	12

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Next Level Private's ABBV Position: Q2 2026 in Review

Next Level Private increased its AbbVie (ABBV) stake by 4% in Q2 2026, buying an estimated $36.1K and bringing the position to 4,398 shares worth $1.11M. The position accounts for 0.22% of the portfolio, ranked #71.

Next Level Private first reported a position in ABBV in Q2 2022 and has held it in 14 quarters since. The position peaked at $3.63M in Q2 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Next Level Private held 4,398 shares of AbbVie worth $1.11M as of Q2 2026.
Next Level Private bought 168 AbbVie shares in Q2 2026, an estimated $36.1K.
AbbVie made up 0.22% of Next Level Private's portfolio in Q2 2026, its #71 holding.
Next Level Private first reported a position in AbbVie in Q2 2022 and has held it in 14 quarters since.
Next Level Private's AbbVie position peaked at $3.63M in Q2 2022.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Next Level Private's 13F filing for Q2 2026, filed 9 Jul 2026.